Equity Investment in Global Biotech
Main Products
- PLENITY
- U.S. FDA-cleared, safe and effective orally-administered weight management product made from naturally derived materials
Main Products
- VXM01
- Innovative oral T-cell immunologist for the treatment of multiple cancers such as recurrent glioblastoma
Main Products
- Diazepam Nasal Spray
- An innovative medicine targeting acute repetitive seizures in patients 6 years of age and older that is convenient to use outside the medical setting and has a very rapid onset of action
Main Products
- PoNS
- A non-invasive portable neuromodulation stimulator for chronic balance deficit due to mild-to-moderate traumatic brain injury
Main Products
- BB2603
- Novel terbinafine-nano spray for the treatment of onychomycosis and tinea pedis that can effectively penetrate human toenails
Main Products
- XF-73
- A new type of nasal colonization antibiotic for the prevention of post-surgical staphylococcal infections and other infectious diseases that can rapidly eliminate drug-resistant staphylococcus aureus and is not susceptible to drug resistance
Main Products
- ACT017
- High-affinity anti-platelet humanized mAb for acute phase of ischemic stroke which does not increase the risk of bleeding
Strategic Collaboration with Global Biopharma
Main Products
- Methylthioninium Chloride Enteric-coated Sustained-release Tablets
- An oral methylene blue sustained-release formulation that enhances diagnosis sensitivity in detecting cancerous/precancerous lesions during colonoscopy
Main Products
- Methotrexate Injection, Pre-filled Syringe
- A Methotrexate (MTX) injection with multiple strength in a small volume, expected to be the first MTX pre-filled injection for subcutaneous administration for the treatment of psoriasis and RA in China
- BCG for Intravesical Instillation
- Launched in Europe for years, the only available BCG preparation for intravesical treatment for non-invasive urothelial bladder carcinoma in many countries
Main Products
- Latanoprost Eye Drops
- A once-a-day, benzalkonium chloride (BAK)-free, novel 0.005% latanoprost ophthalmic formulation
Main Products
- Tildrakizumab Solution for Injection
- A monoclonal antibody specifically targeting IL-23 for the treatment of moderate-to-severe plaque psoriasis
- Cyclosporine Eye Drops 0.09%
- A preservative-free, innovative 0.09% cyclosporine ophthalmic formulation based on globally patented nanotechnology, used for increasing tear secretion in patients with dry eye
Main Products
- CF101
- A selective agonist to the A3 adenosine receptor that is expected to be a novel lead small molecule compound for the basic first-line treatment for psoriasis
- CF102
- A selective agonist to the A3 adenosine receptor for hepatocellular carcinoma and non-alcoholic fatty liver diseases/non-alcoholic steatohepatitis
Main Products
- Desidustat Tablets
- An oral hypoxia-inducible factor-prolyl hydroxylase inhibitor (HIF-PHI) for the treatment of anemia in patients with chronic kidney disease
